Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|June 10, 2008
PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?P L Feldman, M H Lambert, B R HenkeBioorganic & Medicinal Chemistry Letters|July 19, 2001
2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptorB R Henke, D H Drewry, S A Jones, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Identification of a series of oxadiazole-substituted alpha-isopropoxy phenylpropanoic acids with activity on PPARalpha, PPARgamma, and PPARdeltaK G Liu, J S Smith, A H Ayscue, et al.Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Synthesis and biological activity of a novel series of indole-derived PPARgamma agonistsB R Henke, K K Adkison, S G Blanchard, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weightK G Liu, M H Lambert, A H Ayscue, et al.Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.Journal of Medicinal Chemistry|August 15, 1997
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonistsB R Henke, C J Aquino, L S Birkemo, et al.Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.Pageof 2